Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 1, 2005, Pages 19-27

  Fleck, R A ^a   Romero Steiner, S ^b   Nahm, M H ^c  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; OPSONIN; PNEUMOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; BIOASSAY; CELL DIFFERENTIATION; CELL STRAIN HL 60; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE; HUMAN; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; MACROPHAGE; MENINGITIS; NONHUMAN; OPSONIZATION; OTITIS MEDIA; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS; SHORT SURVEY; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

ADULT; ANIMALS; ANTIBODIES, BACTERIAL; BIOLOGICAL ASSAY; CELL DIFFERENTIATION; FEMALE; HL-60 CELLS; HUMANS; MICE; OPSONIN PROTEINS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 12544255422     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.1.19-27.2005     Document Type: Short Survey

References (97)

1. Abbas, A. K., A. H. Lichtman, and J. S. Pober (ed.). 1994. Cellular and molecular immunology, 2nd ed., p. 431-435. W. B. Saunders Co., Philadelphia, Pa.
2. Alonso deVelasco, A. F. M. Verheul, J. Verhoef, and H. Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59:591-603.
3. American Type Culture Collection. 2004. Electronic catalogue. [Online.] http://www.atcc.org/Home.cfm.
4. Atkinson, J. P., and E. A. Jones. 1984. Biosynthesis of human C3b/C4b receptor during differentiation of the HL-60 cell line: identification and characterization of a precursor molecule. J. Clin. Investig. 74:1649-1657.
5. Bailly, A., C. Le Page, M. Rauch, and E. Milgrom. 1986. Sequence-specific DNA binding of the progesterone receptor to the uteroglobin gene: effects of hormone, anti-hormone and receptor phosphorylation. EMBO J. 5:3235-3241.
6. Black, S., H. Shinefield, B. Fireman, E. Lewis, P. Ray, J. Hansen, L. Elvin, K. Ensor, J. Hackell, G. Siber, F. Malinoski, D. Madore, I. Chang, R. Kohberger, W. Watson, R. Austrian, K. Edwards, and the Northern California Kaiser Permanente Vaccine Study Center Group. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19:187-195.
7. Bogaert, D., M. Sluijter, R. de Groot, and P. W. M. Hermans. 2004. Multiplex opsonophagocytosis assay (MOPA) is a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine. Vaccine 22:4014-4020.
8. Boyd, A. W., and D. Metcalf. 1984. Induction of differentiation in HL-60 leukemic cells: a cell cycle dependent all-or-none event. Leuk. Res. 8:27-43.
9. Brietman, T., S. Collins, and B. Keene. 1980. Replacement of serum by insulin and transferring supports growth and differentiation of the human promyelocytic leukemia cell line, HL-60. Exp. Cell. Res. 126:494-498.
10. Bunce, C. M., A. G. Fisher, D. Toksoz, and G. Brown. 1983. Isolation and characterisation of dimethylsulphoxide resistant variants from the human promyeloid cell line HL60. Exp. Hematol. 11:828-833.
11. 3. Leukemia 8:595-604.
12. Bunce, C. M., J. M. Lord, A. K. Y. Wong, and G. Brown. 1988. Near-neighbor analysis of variant cell-lines derived from the promyeloid cell line HL-60. Br. J. Cancer 57:559-563.
13. 3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia 9:410-418.
14. Butler, J. C., E. D. Shapiro, and G. M. Carlone. 1999. Pneumococcal vaccines: history, current status and future directions. Am. J. Med. 107:69S-76S.
15. Cai, T. Q., S. K. A. Law, H. R. Zhao, and S. D. Wright. 1995. Reversible inactivation of purified leukocyte integrin CR3 (CD11b/CD18, α m β 2) by removal of divalent cations from a cryptic site. Cell Adhes. Commun. 3: 399-406.
16. Chi, M., S. Tridandapani, W. Zhong, K. M. Coggeshall, and R. F. Mortensen. 2002. C-reactive protein induces signaling through Fc gamma RIIa on HL-60 granulocytes. J. Immunol. 168:1413-1418.
17. Collins, S. J. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70:1233-1244.
18. Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347-349.
19. Collins, S. J., F. W. Ruscetti, R. E. Gallagher, and R. C. Gallo. 1978. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA 75:2458-2462.
20. Concepcion, N. F., and C. E. Frasch. 2001. Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal- polysaccharide enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 8: 266-272.
21. Corey, S. J. and P. M. Rosoff. 1989. Phagocyte activation, p. 25-42. In M. S. Klempner, B. Styrt, and J. Ho (ed.), Phagocytes and disease. Kluwer Academic Publishers, Dordrecht, The Netherlands.
22. Coughlin, R. T., A. C. White, C. A. Anderson, G. M. Carlone, D. L. Klein, and J. Treanor. 1998. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine 16:1761-1767.
23. Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH. 2004. Electronic catalogue. [Online.] http://www.dsmz.de/dsmzhome.htm.
24. Drexler, H. G. 1987. Myeloid-antigen expression in adult acute lymphoblastic-leukemia. N. Engl. J. Med. 317:1156-1157.
25. Ernst, L. K., J. G. J. van de Winkel, I.-M. Chiu, and C. L. Anderson. 1992. Three genes for the human high affinity Fc receptor for IgG (FCγRI) encode four distinct transcription products. J. Biol. Chem. 267:15692-15700.
26. Eskola, J., T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, E. Herva, A. Takala, H. Kayhty, P. Karma, R. Kohberger, G. Siber, P. H. Makela, S. Lockhart, and M. Ecrola. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344:403-409.
27. European Collection of Cell Cultures. 2004. Electronic catalogue. [Online.] http://www.ecacc.org.uk.
28. Fischkoff, S. A., and R. M. Rossi. 1990. Lineage directed HL-60 cell sublines as a model system for the study of early events in lineage determination of myeloid cells. Leuk. Res. 14:979-988.
29. Fleck, R. A., H. Athwal, J. A. Bygraves, D. J. Hockley, I. M. Feavers, and G. N. Stacey. 2003. Optimization of nb-4 and hl-60 differentiation for use in opsonophagocytosis assays. In Vitro Cell. Dev. Biol. Anim. 39:235-242.
30. Fleck, R. A., and M. H. Nahm. 2004. Characterization of effector cells for a standardized opsonophagocytic killing assay (OPKA) with a pneumococcal target, p. 186. In Proceedings of the 4th International Symposium on Pneumococci and Pneumococcal Diseases. KTL, National Public Health Institute, Helsinki, Finland.
31. Frank, M. M. 1987. Complement in the pathophysiology of human disease. N. Engl. J. Med. 316:1525-1530.
32. Fuller, B. J. 1987. Low temperature preservation in medicine and veterinary science, p. 432-450. In B. W. W. Grout and G. J. Morris (ed.), The effects of low temperatures on biological systems. Edward Arnold, London, United Kingdom.
33. Gallagher, R. S. Collins, J. Trujillo, M. McCredie, M. Ahearn, S. Tsai, R. Metzgar, G. Aulakh, R. Ting, F. Ruscetti, and R. Gallo. 1979. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54:713-733.
34. Gillett, M., R. Care, R. Fleck, J. Bygraves, and I. Feavers. 2004. Cell line and differentiation, choices in the pneumococcal opsonophagocytic killing assay (OPKA), p. 186. In Proceedings of the 4th International Symposium on Pneumococci and Pneumococcal Diseases. KTL, National Public Health Institute, Helsinki, Finland.
35. Gillett, M., R. Care, R. Fleck, J. Bygraves, and I. Feavers. 2004. Establishing a standardized opsonophagocytic killing assay (OPKA) at NIBSC, p. 187. In Proceedings of the 4th International Symposium on Pneumococci and Pneumococcal Diseases. KTL, National Public Health Institute, Helsinki, Finland.
36. Goldberg, Y., C. Glineur, J.-C. Gesquière, A. Ricouart, J. Sap, B. Vennström, and J. Ghysdael. 1988. J. Activation of protein kinase C or camp-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein. EMBO J. 7:2425-2433.
37. Gordon, D. L., and M. K. Hosteller. 1986. Complement and host defence against microorganisms. Pathology 18:365-375.
38. Gordon, D. L., G. M. Johnson, and M. K. Hosteller. 1986. Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes. J. Infect. Dis. 154:619-626.
39. Grillier, I., T. Umiel, E. Elstner, S. J. Collins, and H. P. Koeffler. 1997. Alterations of differentiation, clonal proliferation, cell cycle progression and bcl-2 expression in RAR alpha-altered sublines of HL-60. Leukemia 11: 393-400.
40. Hadjokas, N., C. Bayer, and C. P. Nielson. 1992. Impaired stimulus-response coupling in association with increased growth-rate of HL-60 cells. J. Leukoc. Biol. 52:157-160.
41. Hassan, H. T., E. Petershofem, E. Lux, C. Fonatsch, G. Heil, and M. Freund. 1995. Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture. Ann. Hematol. 71:111-117.
42. Henderson, B., M. Wilson, R. McNab, and A. J. Lax. 1999. The innate immune response, p. 311-353. In B. Henderson, M. Wilson, M.; R. McNab, and A. J. Lax (ed.) Cellular microbiology, bacteria-host interactions in health and disease. John Wiley & Son, Chichester, United Kingdom.
43. Huberman, E., C. Weeks, A. Herrmann, M. Callaham, and T. Slaga. 1981. Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyelocytic leukemia-cells. Proc. Natl. Acad. Sci. USA 78:1062-1066.
44. Interlab Cell Line Collection. 2004. Electronic catalogue [Online.] http://www.iclc.it.
45. Itoh, K., K. Okubo, H. Utiyama, T. Hirano, J. Yoshii, and K. Matsubara. 1998. Expression profile of active genes in granulocytes. Blood 92:1432-1441.
46. Jansen, W. T., M. Väkeväinen-Anttila, H. Käyhty, M. Nahm, N. Bakker, J. Verhoef, H. Snippe, and A. F. Verheul. 2001. Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine. Clin. Diagn. Lab. Immunol. 8:245-250.
47. Jódar, L., J. Butler, G. Carlone, R. Dagan, C. Frasch, D. Goldblatt, H. Käyhty, K. Klugman, B. Plikaytis, G. Siber, R. Kohberger, I. Chang, and T. Cherian. 2003. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine 21: 3265-3272.
48. Juan, H. F., J. Y. C. Lin, W. H. Chang, C. Y. Wu, T. L. Pan, M. J. Tseng, K. H. Khoo, and S. T. Chen. 2002. Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods. Electrophoresis 23:2490-2504.
49. Kim, K. H., and J. Y. Seoh. 2004. Phenotypic and functional analysis of HL-60 cells during induction of differentiation for opsonophagocytic assay, p. 194. In Proceedings of the 4th International Symposium on Pneumococci and Pneumococcal Diseases. KTL, National Public Health Institute, Helsinki, Finland.
50. Kim, K. H., J. Yu, and M. H. Nahm. 2003. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies. Clin. Diagn. Lab. Immunol. 10:616-621.
51. Kubonishi, I., K. Machida, K. Niiya, H. Sonobe, Y. Ohtsuki, K. Iwata, and I. Miyoshi. 1984. Establishment of a new peroxidase-positive human myeloid cell line, P1-21. Blood 63:254-259.
52. Lange, B., M. Valtieri, D. Santoli, D. Caracciolo, F. Mavilio, I. Gemperlein, C. Griffin, B. Emanuel, J. Finan, P. Nowell, and G. Rovera. 1987. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 70:192-199.
53. Lanotte, M., V. Martin-Thouvenin, S. Najman, P. Balerini, F. Valensi, and R. Berger. 1991. NB4, a maturation inducible cell line With t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080-1086.
54. Lin, J. S., M. K. Park, and M. H. Nahm. 2001. Chromogenic assay measuring opsonophagocytic killing capacities of antipneumococcal antisera. Clin. Diagn. Lab. Immunol. 8:528-533.
55. Martinez, J., E. Clutterbuck, S. Romero-Steiner, L. L. Wood, and G. M. Carlone. 2002. Development of a multiplexed, bead-based, flow cytometric, opsonophagocytic assay for the simultaneous detection of antibody to multiple Streptococcus pneumoniae serotypes, p. 79-80. In Proceedings of the 3rd International Symposium on Pneumococci and Pneumococcal Diseases. Centers for Disease Control and Prevention. Anchorage, Alaska.
56. Martinez, J. E., S. Romero-Steiner, E. Clutterbuck, and G. M. Carlone. 2002. Performance of a multiplexed Streptococcus pneumoniae flow cytometric opsonophagocytic assay, p. 27. In Proceedings of the 3rd International Symposium on Pneumococci and Pneumococcal Diseases. Centers for Disease Control and Prevention, Anchorage, Alaska.
57. Martinez, J. E., S. Romero-Steiner, T. Pilishvili, S. Barnard, J. Schinsky, D. Goldblatt, and G. M. Carlone. 1999. A flow cytometric opsonophagocytic assay for the measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immunol. 6:581-586.
58. Mascioli, D. W., and R. D. Estensen. 1984. Analysis of human promyelocytic leukemia-cell (HL60) variants insensitive to phorbol ester tumor promoters. Cancer Res. 44:3280-3285.
59. Mata-Greenwood, E., A. Ito, H. Westenburg, B. Cui, R. G. Mehta, A. D. Kinghorn, and J. M. Pezzuto. 2001. Discovery of novel inducers of cellular differentiation using HL-60 promyelocytic cells. Anticancer Res. 21:1763-1770.
60. Mazur, P. 1970. Cryobiology: the freezing of biological systems. Science 168: 939-949.
61. Miyamura, K., E. Tajiri, A. Ito, R. Murata, and R. Kono. 1974. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies. J. Biol. Stand. 2:203-209.
62. Musher, D. M., D. W. Watson, and R. E. Baughn. 1990. Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infections? J. Infect. Dis. 161:736-740.
63. Musher, D. M., A. J. Chapman, A. Goree, S. Jonsson, D. E. Briles, and R. E Baughn. 1986. Natural and vaccine related immunity to Streptococcus pneumoniae: prevalence, persistence, and response to re-vaccination. J. Infect. Dis. 154:245-256.
64. Nahm, M. H. (ed.) 2004. Opsonophagocytosis protocol [Online.] http://www.vaccine.uab.edu.
65. Nahm, M. H., D. E. Briles, and X. Yu. 2000. Development of a multispecificity opsonophagocytic killing assay. Vaccine 18:2768-2771.
66. Nauseef, W. M. 1989. Ontogeny of phagocytes, p. 1-23. In M. S. Klempner, B. Styrt, and J. Ho (ed.), Phagocytes and disease. Kluwer Academic Publishers, Dordrecht. The Netherlands.
67. Nishino, T., N. Raise, Y. Sindo, N. Nishino, T. Nishida, S. Yasuda, and Y. Masui. 1991. Promyelocytic leukemia-cell line, HL-60, produces human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 181:323-330.
68. Ohyashiki, K., J. H. Ohyashiki, and A. A. Sandberg. 1986. Cytogenetic characterization of putative human myeloblastic leukaemia cell lines (ML-1, -2, and -3): origin of the cells. Cancer Res. 46:3642-3647.
69. Osborne, J. M., G. W. Chacko, J. T. Brandt, and C. L. Anderson. 1994. Ethnic variation in frequency of an allelic polymorphism of human Fc gamma RIIa determined with allele specific oligonucleotide probes. J. Immunol. Methods 173:207-217.
70. Patzke, S., M. Lindeskog, E. Munthe, and H. C. Aasheim. 2002. Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines. Virology 303:164-173.
71. Polge, C., A. U. Smith, and A. S. Parkes. 1949. Revival of spermatazoa after vitrification and dehydration at low temperatures. Nature 164:666.
72. Romero-Steiner, S., C. Frasch, N. Conception, D. Goldblatt, H. Käyhty, M. Väkeväinen, C. Laferriere, D. Wauters, M. H. Nahm, M. F. Schinsky, B. D. Plikaytis, and G. M. Carlone. 2003. Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin. Diagn. Lab. Immunol. 10:1019-1024.
73. Romero-Steiner, S., D. Libutti, L B. Pais, J. Dykes, P. Anderson, J. C. Whitin, H. L. Keyserling, and G. M. Carlone. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
74. Rovera, G., D. Santoli, and C. Damsky. 1979. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with phorbol diester. Proc. Natl. Acad. Sci. USA 76:2779-2783.
75. Ryynänen, M., K. Jousimies, N. Nikkanen, H. Käyhty, and N. Ekström. 2004. Multiplexed and single-colour flow cytometric opsonophagocytosis assays for detection of functional pneumococcal antibodies in infant sera, p. 230. In Proceedings of the 4th International Symposium on Pneumococci and Pneumococcal Diseases. KTL, National Public Health Institute, Helsinki, Finland.
76. 3-dependent differentiation of HL-60 cells: a cDNA array study. Br. J. Hematol. 118:1065-1070.
77. Sanders, L. A. M., J. G. J. van de Winkel, G. T. Rijkers, M. M. Voorhorst-Orgink, M. de Haas, P. J. A. Capel, and B. J. M. Zegers. 1994. Fcγ receptor IIa (CD 32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J. Infect. Dis. 170:854-861.
78. Shapiro, E. D., A. T. Berg, R Austrian, D. Schroeder, V. Parcells. A. Margolis. R. K. Adair, and J. D. Clemens. 1991. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:1453-1460.
79. Shellhaas, J. L., and S. H. Zuckerman. 1995. In vitro detection of apoptotic stimuli by use of the HL-60 myeloid leukemic cell line. Clin. Diagn. Lab. Immunol. 2:598-603.
80. Skubitz, K. M., Y.-S. Zhen, and J. T. August. 1982. Dexamethasone synergistically induces chemotactic peptide receptor expression in HL-60 cells. Blood 59:586-593.
81. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17:565-577.
82. Tarella, C., D. Ferrero, E. Gallo, G. L. Pagliardi, and F. W. Ruscetti. 1982. Induction of differentiation of HL-60 cells by dimethylsulfoxide: evidence for a stochastic model not linked to the cell division cycle. Cancer Res. 42: 445-449.
83. Tellado, J. M., and N. V. Christou. 1993. Activation state of polymorphonuclear leukocytes in surgical patients: characterization of surface receptor expression. Surgery 113:624-630.
84. Todaro, G. J., and H. Green. 1963. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:299-313.
85. Tomonaga, M., D. W. Golde, and J. C. Gasson. 1986. Biosynthetic (recombinant) human granulocyte-macrophage colony-stimulating factor: effect on normal bone marrow and leukemia cell lines. Blood 67:31-36.
86. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
87. Väkeväinen, M., W. Jansen, E. Saeland, I. Jonsdottir, H. Snippe, A. Verbeul, and H. Käyhty. 2001. Are opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable? Clin. Diagn. Lab. Immunol. 8:363-369.
88. Valtieri, M., G. Boccoli, U. Testa, C. Barletta, and C. Peschle. 1991. Two-step differentiation of AML-193 leukemic line: terminal maturation is induced by positive interaction of retinoic acid with granulocyte colony-stimulating factor (CSF) and vitamin D3 with monocyte CSF. Blood 77:1804-1812.
89. Van de Winkel, J. G. J., and C. L. Anderson. 1991. Biology of human immunoglobulin G Fc receptors. J. Leukoc. Biol. 49:511-524.
90. Vidarsson, G., I. Jonsdottir, S. Jonsson, and H. Valdimarsson. 1994. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. J. Infect. Dis. 170:592-599.
91. Wernette, C. M., C. E. Frasch, D. Madore, G. Carlone, D. Goldblatt, B. Plikaytis, W. Benjamin, S. A. Quataert, S. Hildreth, D. J. Sikkema, H. Kayhty, I. Jonsdottir, and N. H. Nahm. 2003. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin. Diagn. Lab. Immunol. 10:514-519.
92. Wiener, E., R. A. Dellow, F. Mawas, and C. H. Rodeck. 1996. Role of Fc gamma RIIa (CD32) in IgG anti-RhD-mediated red cell phagocytosis in vitro. Transfus. Med. 6:235-241.
93. Wilkestein, J. A., M. R. Smith, and H. S. Shin. 1975. The role of C3 as an opsonin in the early stages of infection. Proc. Soc. Exp. Biol. Med. 149: 397-401.
94. Williams, J. H., Jr., M. V. Pahl, D. Kwong, J. Zhang, D. Hatakeyama, K. Ahmad, M. Naderi, M. Kim, and N. Vaziri. 2003. Modulation of neutrophil complement receptor 3 expression by pneumococci. Clin. Sci. 104:615-625.
95. 2 activity in undifferentiated and neutrophil-like HL-60 cells. J. Biol. Chem. 269:3117-3124.
96. Yu, X., Y. Sun, C. Frasch, N. Concepcion, and M. H. Nahm. 1999. Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic. Clin. Diagn. Lab. Immunol. 6: 519-524.
97. Zieglerheitbrock, H. W. L, E. Thiel, A. Futterer, V. Herzog, A. Wirtz, and G. Riethmuller. 1988. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 41:456-461.